Concepedia

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective

Craig D. Seaman, Kenneth J. Smith, Margaret V. Ragni

Thrombosis Research · 2013 · 42 citations · 12 references

DOI

Concepts

References

12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2010 · 3.2K citations · Full text

, , +16

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

New England Journal of Medicine · 2012 · 2.3K citations · Full text

, , +15

Executive Summary

Gordon Guyatt, Elie A. Akl, Mark Crowther et al. · CHEST Journal · 2012 · 1.5K citations · Full text

, , +16

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

R. Scott Braithwaite, David Meltzer, Joseph T. King et al. · Medical Care · 2008 · 585 citations

, , +17